World Health Organization 28 October, 2019 Countries using and planning to introduce IPV and the global status of bOPV registration

Countries using and planning to introduce IPV June 2016 status report World Health Organization 28 October 2019 Countries using and planning to introduce IPV June 2016 status report This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). It also includes a summary of the global status of national registration of bivalent Oral Polio Vaccine (bOPV), in preparation for the switch from trivalent OPV (tOPV) to bOPV. Information here is updated monthly based on information shared by WHO and UNICEF Regional Offices. Please contact polio2@who.int with any questions or updates on this data. Definitions Formal decision to introduce: The country has documentation of its decision to introduce IPV which has been verified by the relevant WHO Regional Office, or for Gavi eligible countries, a complete application for IPV has been submitted to the Gavi Secretariat. Tracking these decisions and informal intents provide an indication of the global trend towards meeting the targets of the Polio Eradication and Endgame Strategic Plan.

Countries using IPV vaccine to date and formal decision to introduce World Health Organization Countries using IPV vaccine to date and formal decision to introduce 28 October, 2019 Introduced to date Afghanistan Albania Algeria Andorra Antigua and Barbuda Argentina Australia Austria Azerbaijan Bahamas (the) Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burundi Cambodia Cameroon Canada Central African Republic (the) Chad Chile China Colombia Comoros (the) Congo (the) Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic (the) Denmark Djibouti Dominica Dominican Republic (the) DPR Korea DR Congo Ecuador El Salvador Estonia Ethiopia Fiji Finland France Gabon Gambia (the) Georgia Germany Greece Grenada Guatemala Guinea Guyana Haiti Honduras Hungary Iceland India Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Lao People's Democratic Republic (the) Latvia Lebanon Lesotho Libya Lithuania Luxembourg Madagascar Malaysia Maldives Mali Malta Marshall Islands (the) Mauritania Mauritius Mexico Micronesia (Federated States of) Monaco Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands (the) New Zealand Nicaragua Niger (the) Nigeria Niue Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines (the) Poland Portugal Qatar Rep of Korea Romania Russian Federation (the) Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka Sudan (the) Suriname Sweden Switzerland Syrian Arab Republic (the) Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tonga Trinidad and Tobago Tunisia Turkey Tuvalu Uganda Ukraine United Arab Emirates (the) United Kingdom of Great Britain and Northern Ireland (the) United States of America (the) Uruguay Vanuatu Venezuela (Bolivarian Republic of) Yemen Formal commitment to introduce in 2016 Armenia Cabo Verde Equatorial Guinea Guinea-Bissau Indonesia Swaziland Introduction delayed to 2017 Angola Burkina Faso Egypt Eritrea Ghana Kyrgyzstan Liberia Malawi Mongolia Republic of Moldova (the) Rwanda Sierra Leone Tajikistan Togo Turkmenistan United Republic of Tanzania (the) Uzbekistan Viet Nam Zambia Zimbabwe Since January 2013, the following countries have introduced IPV: Kazakhstan, Peru & Singapore (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Grenada, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan, Philippines & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015); Bahamas, Lao People's Dem Rep, Nauru, Samoa (October 2015); Antigua and Barbuda, Botswana, Burundi, Cook Islands, Guinea, India, Mauritania, Mauritius, Mozambique, Namibia, Nicaragua, St Lucia, Suriname, Tuvalu, Vanuatu & Yemen (November 2015); Algeria, Belize, Cambodia, Dominical Rep, Ecuador, Ethiopia, Fiji, Gabon, Georgia, Honduras, Kenya, Myanmar, Paraguay, St Kitts & Nevis, S. Sudan, Thailand, Tonga & Trinidad & Tobago (December 2015); Cuba, El Salvador, Guatemala, Haiti, Iraq & Venezuela (Bolivian Rep of) (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Chile & Mali (March 2016); Argentina, Congo, Djibouti, Lesotho, Sao Tome & P., Uganda (April 2016) Introduced to date* (168 countries or 87%) Formal commitment to introduce in 2016 (6 countries or 3%) Introduction delayed in 2017 (20 countries or 10%) Not available Not applicable Data source: WHO/IVB Database, as of 01 June 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization * Including partial introduction in India The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Date of slide: 1 June 2016

World Health Organization Countries using IPV vaccine to date and introductions planned according to Gavi eligibility status World Health Organization 28 October, 2019 Introduced to date Afghanistan Albania Algeria Andorra Antigua and Barbuda Argentina Australia Austria Azerbaijan Bahamas (the) Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burundi Cambodia Cameroon Canada Central African Republic (the) Chad Chile China Colombia Comoros (the) Congo (the) Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic (the) Denmark Djibouti Dominica Dominican Republic (the) DPR Korea DR Congo Ecuador El Salvador Estonia Ethiopia Fiji Finland France Gabon Gambia (the) Georgia Germany Greece Grenada Guatemala Guinea Guyana Haiti Honduras Hungary Iceland India Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Lao People's Democratic Republic (the) Latvia Lebanon Lesotho Libya Lithuania Luxembourg Madagascar Malaysia Maldives Mali Malta Marshall Islands (the) Mauritania Mauritius Mexico Micronesia (Federated States of) Monaco Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands (the) New Zealand Nicaragua Niger (the) Nigeria Niue Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines (the) Poland Portugal Qatar Rep of Korea Romania Russian Federation (the) Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka Sudan (the) Suriname Sweden Switzerland Syrian Arab Republic (the) Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tonga Trinidad and Tobago Tunisia Turkey Tuvalu Uganda Ukraine United Arab Emirates (the) United Kingdom of Great Britain and Northern Ireland (the) United States of America (the) Uruguay Vanuatu Venezuela (Bolivarian Republic of) Yemen Gavi countries with formal commitment to introduce in 2016-2017 Angola Armenia Burkina Faso Eritrea Ghana Guinea-Bissau Indonesia Kyrgyzstan Liberia Malawi Mongolia Republic of Moldova (the) Rwanda Sierra Leone Tajikistan Togo United Republic of Tanzania (the) Uzbekistan Viet Nam Zambia Zimbabwe Non Gavi countries with formal commitment to introduce in 2016-2017 Cabo Verde, Egypt, Equatorial Guinea, Swaziland, Turkmenistan Since January 2013, the following countries have introduced IPV: Kazakhstan, Peru & Singapore (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Grenada, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan, Philippines & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015); Bahamas, Lao People's Dem Rep, Nauru, Samoa (October 2015); Antigua and Barbuda, Botswana, Burundi, Cook Islands, Guinea, India, Mauritania, Mauritius, Mozambique, Namibia, Nicaragua, St Lucia, Suriname, Tuvalu, Vanuatu & Yemen (November 2015); Algeria, Belize, Cambodia, Dominical Rep, Ecuador, Ethiopia, Fiji, Gabon, Georgia, Honduras, Kenya, Myanmar, Paraguay, St Kitts & Nevis, S. Sudan, Thailand, Tonga & Trinidad & Tobago (December 2015); Cuba, El Salvador, Guatemala, Haiti, Iraq & Venezuela (Bolivian Rep of) (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Chile & Mali (March 2016); Argentina, Congo, Djibouti, Lesotho, Sao Tome & P., Uganda (April 2016) Introduced to date* (168 countries or 87%) Gavi countries with formal commitment to introduce in 2016-2017 (21 countries or 10%) Non Gavi countries with formal commitment to introduce in 2016-2017 (5 countries or 3%) Not available Data source: WHO/IVB Database, as of 01 June 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Not applicable * Including partial introduction in India The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Date of slide: 1 June 2016

26 countries introducing IPV between 1 June 2016 and December 2017 World Health Organization 26 countries introducing IPV between 1 June 2016 and December 2017 28 October, 2019 June – July 2016 December 2017 Armenia Angola Cabo Verde Burkina Faso Equatorial Guinea Egypt Guinea-Bissau Eritrea Indonesia Ghana Swaziland Kyrgyzstan   Liberia Malawi Mongolia Rep. of Moldova Rwanda Sierra Leone Tajikistan Togo Turkmenistan United Rep. of Tanzania Uzbekistan Viet Nam Zambia Zimbabwe 6 20 Legend Tier 2 countries Data source: WHO/IVB Database, as of 01 June 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /medium size countries with DTP3 coverage <80% in the past 3 years as per WUENIC

World Health Organization Tier 1 and 2 Countries using IPV vaccine to date and formal decision to introduce 28 October, 2019 Introduction to date Afghanistan Azerbaijan Benin Cambodia Cameroon Central African Republic (the) Chad China Congo (the) Dominican Republic (the) DR Congo Ethiopia Gabon Guinea Haiti India Iraq Kenya Lao People's Democratic Republic (the) Madagascar Mali Mauritania Mozambique Myanmar Niger (the) Nigeria Pakistan Papua New Guinea Philippines (the) Somalia South Sudan Timor-Leste Uganda Yemen Formal commitment to introduce in 2016-2017 Equatorial Guinea, Indonesia Not Applicable or not Tier 1 or 2 countries Angola, Albania, Andorra, United Arab Emirates (the), Argentina, Armenia, Antigua and Barbuda, Australia, Austria, Burundi, Belgium, Burkina Faso, Bangladesh, Bulgaria, Bahrain, Bahamas (the), Bosnia and Herzegovina, Belarus, Belize, Bolivia (Plurinational State of), Brazil, Barbados, Brunei Darussalam, Bhutan, Botswana, Canada, Switzerland, Chile, Cote d'Ivoire, Cook Islands, Colombia, Comoros (the), Cabo Verde, Costa Rica, Cuba, Cyprus, Czech Republic (the), Germany, Djibouti, Dominica, Denmark, Algeria, Ecuador, Egypt, Eritrea, Spain, Estonia, Finland, Fiji, France, Micronesia (Federated States of), United Kingdom of Great Britain and Northern Ireland (the), Georgia, Ghana, Gambia (the), Guinea-Bissau, Greece, Grenada, Guatemala, Guyana, Honduras, Croatia, Hungary, Ireland, Iran (Islamic Republic of), Iceland, Israel, Italy, Jamaica, Jordan, Japan, Kazakhstan, Kyrgyzstan, Kiribati, Saint Kitts and Nevis, Rep of Korea, Kuwait, Lebanon, Liberia, Libya, Saint Lucia, Sri Lanka, Lesotho, Lithuania, Luxembourg, Latvia, Morocco, Monaco, Republic of Moldova (the), Maldives, Mexico, Marshall Islands (the), The former Yugoslav Republic of Macedonia, Malta, Montenegro, Mongolia, Mauritius, Malawi, Malaysia, Namibia, Nicaragua, Niue, Netherlands (the), Norway, Nepal, Nauru, New Zealand, Oman, Panama, Peru, Palau, Poland, DPR Korea, Portugal, Paraguay, Qatar, Romania, Russian Federation (the), Rwanda, Saudi Arabia, Sudan (the), Senegal, Singapore, Solomon Islands, Sierra Leone, El Salvador, San Marino, Serbia, Sao Tome and Principe, Suriname, Slovakia, Slovenia, Sweden, Swaziland, Seychelles, Syrian Arab Republic (the), Togo, Thailand, Tajikistan, Turkmenistan, Tonga, Trinidad and Tobago, Tunisia, Turkey, Tuvalu, United Republic of Tanzania (the), Ukraine, Uruguay, United States of America (the), Uzbekistan, Saint Vincent and the Grenadines, Venezuela (Bolivarian Republic of), Viet Nam, Vanuatu, Samoa, South Africa, Zambia, Zimbabwe Since January 2013, the following Tier 1 and 2 countries have introduced IPV: The Philippines (October 2014), China (December 2014), Nigeria (February 2015), DR Congo (April 2015), Madagascar (May 2015), Cameroon, Niger and Pakistan (July 2015); Benin, Chad and Papua New Guinea (August 2015); Afghanistan and CAR (September 2015); Lao People's Democratic Republic (October 2015); Guinea, India, Mauritania, Mozambique, Somalia & Yemen (November 2015); Cambodia, Dominican Rep., Ethiopia, Gabon, Kenya, Myanmar & S. Sudan (December 2015); Haiti & Iraq (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Mali (March 2016); Congo & Uganda (April 2016) Introduced to date* (34 countries or 94%) Formal commitment to introduce in 2016 (2 countries or 6%) Not applicable / not available / not Tier 1 or 2 countries * Including partial introduction in India Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /Medium size countries with DTP3 coverage <80% in the past 3 years as per WUENIC Data source: WHO/IVB Database, as of 01 June 2016, based on 36 tier 1 & 2 countries Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Date of slide: 1 June 2016

World Health Organization Middle Income Countries using IPV vaccine to date and formal decision to introduce 28 October, 2019 Introduced to date Albania Algeria Azerbaijan Bangladesh Belarus Belize Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Bulgaria Cameroon China Colombia Congo (the) Costa Rica Cote d'Ivoire Cuba Djibouti Dominica Dominican Republic (the) Ecuador El Salvador Fiji Gabon Georgia Grenada Guatemala Guyana Honduras India Iran (Islamic Republic of) Iraq Jamaica Jordan Kazakhstan Kenya Kiribati Lao People's Democratic Republic (the) Lebanon Lesotho Libya Malaysia Maldives Marshall Islands (the) Mauritania Mauritius Mexico Micronesia (Federated States of) Montenegro Morocco Myanmar Namibia Nicaragua Nigeria Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines (the) Romania Saint Lucia Saint Vincent and the Grenadines Samoa Sao Tome and Principe Senegal Serbia Solomon Islands South Africa Sri Lanka Sudan (the) Suriname Syrian Arab Republic (the) Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tonga Tunisia Turkey Tuvalu Ukraine Vanuatu Yemen Formal commitment to introduce in 2016-2017 Angola Armenia Cabo Verde Egypt Ghana Indonesia Kyrgyzstan Mongolia Republic of Moldova (the) Swaziland Tajikistan Turkmenistan Uzbekistan Viet Nam Zambia Since January 2013, the following MIC have introduced IPV: Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Tunisia (September 2014); Philippines (October 2014); China (December 2014); Senegal (January 2015); Serbia (January 2015); Colombia (February 2015); Maldives (March 2015) and Cote d'Ivoire, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Pakistan & Sri Lanka (July 2015); Papua New Guinea & the former Yugoslav Rep. of Macedonia (August 2015); Dominica, Guyana, Iran, Jamaica & Solomon Islands (September 2015); Lao People's Democratic Rep & Samoa (October 2015); Botswana, India, Mauritania, Mauritius, Namibia, Nicaragua, St Lucia, Tuvalu , Vanuatu & Yemen (November 2015); Algeria, Belize, Dominican Rep, Ecuador, Fiji, Gabon, Georgia, Honduras, Kenya, Myanmar, Paraguay, Thailand & Tonga (December 2015); Cuba, El Salvador, Iraq & Guatemala (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Congo, Djibouti, Lesotho & Sao Tome & P. (April 2016) Introduced to date (86 countries or 85%) Formal commitment to introduce in 2016-2017 (15 countries or 15%) Data source: WHO/IVB Database, as of 01 June 2016 based on 101 middle income countries (MIC) as per last World Bank classification Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Not applicable / not available / Not introduced / Non MIC The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Date of slide: 1 June 2016

World Health Organization 28 October, 2019 Overview of Global birth cohort by IPV status/tier (100% = 140.1 million births in 2016) * Partial Introduction Data source: WHO/IVB Database, as of 01 June 2016 and United Nations, Department of Economic and Social Affairs, Population Division (2015). World Population Prospects: The 2015 Revision

bOPV registration status for routine immunization World Health Organization 28 October, 2019 Approval for use Afghanistan, Albania, Algeria, Angola, Antigua and Barbuda, Argentina, Armenia, Azerbaijan, Bahamas (the), Bahrain, Bangladesh, Barbados, Belize, Benin, Bhutan, Bolivia (Plurinational State of), Bosnia and Herzegovina, Botswana, Brazil, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Central African Republic (the), Chile, China, Colombia, Comoros (the), Congo (the), Cook Islands, Cote d'Ivoire, Djibouti, Dominica, Dominican Republic (the), DPR Korea, DR Congo, Ecuador, Egypt, El Salvador, Equatorial Guinea, Fiji, Gabon, Gambia (the), Georgia, Ghana, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, India, Indonesia, Iran (Islamic Republic of), Iraq, Israel, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic (the), Lebanon, Lesotho, Liberia, Libya, Madagascar, Malawi, Maldives, Mali, Mauritius, Mongolia, Myanmar, Nauru, Nepal, Nicaragua, Niger (the), Nigeria, Oman, Pakistan, Panama, Papua New Guinea, Paraguay, Peru, Philippines (the), Republic of Moldova (the), Russian Federation (the), Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Saudi Arabia, Serbia, Seychelles, Sierra Leone, Singapore, Solomon Islands, Somalia, South Africa, South Sudan, Sri Lanka, Sudan (the), Suriname, Swaziland, Syrian Arab Republic (the), Tajikistan, Thailand, The former Yugoslav Republic of Macedonia, Timor-Leste, Tonga, Trinidad and Tobago, Turkmenistan, Ukraine, United Arab Emirates (the), Uzbekistan, Vanuatu, Venezuela (Bolivarian Republic of), Viet Nam, Yemen Review in progress Mexico Approval for use (143 countries ) Review in progress (1 country - Mexico) Data source: WHO/IVB Database, as of 01 June 2016 based on 148 OPV user countries and 7 Territories Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Not available/ non switch countries (46 countries) + 4 countries switching from tOPV to IPV Not applicable (switch area territories) The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Date of slide: 1 June 2016